The downgrade is based on several factors, including Bethesda’s multiple years of challenged operating performance.
The outlook is negative, reflecting Bethesda’s ongoing challenges regarding operating performance and operating leverage.
More articles on healthcare finance:
Following budget impasse, hospitals see delay in medical treatment, rise in cash payments
Under Medicare Part B changes, reimbursement tipping point at $480 a day per drug: 5 cost findings from Avalere
Meet the online medical billing and coding training company that already has 1 million views on YouTube
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
